WhatsApp

Wegovy Injection in Dubai: Price, Benefits, Where to Buy & More

Picture of Dr. Hecham Harb

Dr. Hecham Harb

Consultant Endocrinologist & Medical Director

Wegovy Injection in Dubai - Price, Results, Eligibility & More

Book Your Consultation

  • Specialist consultation
  • Personalized Coaching
  • Body Composition Analysis
Book your consultation

01  Quick answer

Wegovy is a once-weekly, prescription-only GLP-1 injection that uses semaglutide to support medically supervised weight loss. In Dubai, it must be prescribed by a licensed doctor after a proper clinical assessment. At Endocare Clinic in Dubai Healthcare City, Wegovy is delivered as part of a structured programme that pairs endocrinology-led care with body-composition tracking, lifestyle coaching and ongoing follow-up.

 

Key takeaways

  • Wegovy is semaglutide, a GLP-1 receptor agonist taken as a once-weekly subcutaneous injection.
  • In Dubai it is prescription-only and is escalated gradually from 0.25 mg up to 2.4 mg weekly.
  • Eligibility starts at the WHO obesity threshold of BMI 30, or BMI 27 with a weight-related condition such as prediabetes, hypertension or PCOS. It is also approved for adolescents aged 12 and older who meet medical criteria.
  • STEP 1 trial data showed an average body-weight reduction of about 15 percent at 68 weeks. At Endocare, patients on the supervised programme typically lose 3 to 4 kg per month.
  • Wegovy works best alongside nutrition, movement, sleep and stress support. It is not a standalone fix.
  • In the SELECT trial it was also shown to reduce the risk of major cardiovascular events such as heart attack and stroke in adults with overweight or obesity and established heart disease.

Calculate your expected weight loss with Wegovy

Your current weight:
75 kg
You can lose up to:
15 kg

Calculate your expected weight loss

Your
current weight:
75 kg
You can
lose up to:
15 kg

If you have been reading about Wegovy in Dubai and trying to work out whether it is right for you, you are in good company. More patients than ever are looking past short-term diets and asking whether a medically supervised option could help them lose weight in a way that actually lasts.

 

Wegovy is one of the most widely studied medications used in this space, and the questions that come up are nearly always the same. How does it work. Who is it actually for. What kind of results are realistic. What does it cost in Dubai. Where should you get it from. Is it safe.

 

This page answers those questions in a clear, clinical way, and explains how Wegovy is prescribed at Endocare Clinic in Dubai Healthcare City. No hype, no miracle claims, just the information you need to make an informed decision with your doctor.

 

If you are based outside Dubai, you can also visit our Wegovy in Abu Dhabi page or the Wegovy UAE overview.

Wegovy is a prescription medication used in structured, doctor-led weight-management programmes per the FDA prescribing information for Wegovy. It contains the active ingredient semaglutide, a molecule that belongs to a class of medicines called GLP-1 receptor agonists. It is given as a once-weekly subcutaneous injection, which means it goes just under the skin, not into a muscle or vein.

 

GLP-1 is a natural gut hormone your body already makes. It helps regulate appetite, slows the rate at which food leaves the stomach, and supports steadier blood sugar responses after meals. Wegovy mimics this hormone, which is why patients on treatment often notice fewer cravings, smaller portions feeling more satisfying, and a calmer relationship with food.

 

In Dubai, Wegovy is prescribed through licensed clinics after a doctor reviews your BMI, your medical history and any underlying conditions. It is not a cosmetic product. It is a medical therapy that influences appetite signalling and digestion at a hormonal level, which is why ongoing supervision matters.

 

At Endocare, Wegovy is offered as part of a supervised programme focused on safety, consistency and long-term metabolic health, rather than as a standalone prescription. The programme is designed to do two things. It aims to increase the weight loss you achieve while you are on treatment, and it helps you hold on to that new weight after the medication is eventually stopped. This is where the lifestyle changes come in. By addressing the underlying habits and root causes that contributed to weight gain in the first place, patients are better equipped to maintain their results over the long term.

 

These ideas are often misunderstood online, and we untangle them in our overview of common myths about weight loss injections

Eligibility is never decided on symptoms alone. A proper assessment looks at your weight, your health history and any factors that might make Wegovy unsuitable or unsafe for you.

 

Wegovy is generally prescribed for adults if:

 

 

Wegovy is also approved for adolescents aged 12 and older who meet medical criteria for obesity, as shown in the STEP TEENS trial. In this age group, treatment is used alongside a reduced-calorie diet and increased physical activity, under careful medical supervision.

 

Certain people should not start Wegovy, or need further evaluation before treatment can be considered:

 

  • Women who are pregnant or breastfeeding
  • Anyone with a personal or family history of medullary thyroid carcinoma
  • Anyone with a personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Patients with severe gastrointestinal disorders
  • Anyone with a prior episode of pancreatitis
  • Patients on medications that may interact with GLP-1 therapies
 

If you are unsure whether you qualify, a structured assessment at a licensed Wegovy clinic in Dubai is the right next step. That conversation should always come before a prescription.

 

For broader context on how hormonal imbalance can contribute to weight gain, especially in women, see our guide on weight loss and hormonal imbalance.

 

Patients with metabolic syndrome often benefit most from supervised GLP-1 therapy. We cover this in our guide to losing weight with metabolic syndrome.

This is one of the most common questions before starting treatment, and it deserves an honest answer. Wegovy is designed to support gradual, sustainable weight reduction, not rapid or extreme loss.

 

The STEP 1 trial, the pivotal study used for Wegovy approval, reported an average body-weight reduction of about 15 percent at 68 weeks when semaglutide 2.4 mg was combined with lifestyle changes. The SELECT cardiovascular trial, which looked at adults with overweight or obesity and established cardiovascular disease, also showed a 20 percent reduction in major adverse cardiovascular events.

 

In real-world supervised programmes, results vary based on starting weight, dose progression, consistency with treatment, and lifestyle habits. At Endocare, patients on the supervised programme typically lose about 3 to 4 kg per month, and many achieve close to 13 kg over the first three months when lifestyle coaching is followed alongside medication.

 

A typical timeline often looks like this:

 

  • Weeks 1 to 4: appetite changes and smaller portion sizes start to feel natural.
  • Months 2 to 4: more noticeable changes in eating patterns and on the scale.
  • Month 6 and beyond: steadier progress as appetite regulation stabilises.

 

For patients who continue treatment longer term, the STEP 4 weight-maintenance trial showed that ongoing semaglutide therapy supports maintained weight loss versus discontinuation.

 

Two points are worth being clear about. Outcomes are individual, and no clinic can promise a specific number on the scale. And lifestyle change is not optional. Patients who address the habits driving weight gain see better, more durable results than patients who rely on medication alone. That is why Endocare integrates nutritionist and coaching support into every programme.

Wegovy is introduced gradually so the body can adapt. Starting at a full dose is more likely to cause side effects, so treatment follows a structured escalation.

 

 

A typical dose schedule looks like this:

 

  • 25 mg once weekly
  • 5 mg once weekly
  • 1 mg once weekly
  • 7 mg once weekly
  • 4 mg once weekly
 

Dose increases happen at medically appropriate intervals, and only when the current dose is well tolerated. Not everyone needs the maximum 2.4 mg dose, and the final dose is decided based on weight-loss progression, tolerance and your overall clinical response.

 

 

This step-by-step approach supports better digestive comfort during early treatment, more consistent appetite regulation over time, and safer progress overall.

 

 

If you are curious about an oral version, see our explainer on whether there is a Wegovy pill.

Wegovy is given as a once-weekly subcutaneous injection, taken on the same day each week. Patients receive practical training from their clinic, usually during the first visit.

 

 

Approved injection sites are:

 

  • Abdomen
  • Thigh
  • Upper arm
 

Rotate the site each week rather than injecting into the same exact spot. This reduces skin irritation and supports better absorption.

 

 

Storage is straightforward but important:

 

  • Wegovy pens should be kept in the fridge at 2 to 8 °C.
  • Pens can be kept at room temperature for up to 28 days if refrigeration is not possible.
 

Used pens should be disposed of safely according to your clinic’s instructions. If you are travelling or unsure how to store your pen, ask your clinic before the trip rather than after.

Like any prescription medication, Wegovy can cause side effects, especially during the first few weeks and on dose increases. Most are temporary and improve as your body adjusts.

 

Commonly reported side effects include:

 

  • Nausea
  • Bloating or feeling full early in a meal
  • Changes in bowel habits
  • Reduced appetite
 

Less common but important symptoms to report straight away include:

 

  • Persistent vomiting
  • Severe abdominal pain
  • Signs of dehydration
 

In practice, most side effects can be managed by slowing dose escalation, adjusting timing, improving hydration and making small changes to meals. This is one of the reasons supervised treatment matters. Your dose can be tailored to how you actually feel, rather than rushed for the sake of speed.

 

You can read more about safety considerations in our piece on medical weight loss safety and on GLP-1 therapy under medical supervision.

 

For independent European safety information, you can also review the EMA Wegovy product information.

Cost matters, especially because Wegovy is a long-term treatment rather than a one-off purchase. At Endocare, the price you pay reflects more than just the medication. It includes specialist consultations, body-composition analysis, lab tests where needed, and lifestyle coaching, which are all part of safe, supervised use.

 

The Wegovy medication itself is priced by dose. The standard UAE prices are:

 

  • 25 mg: 734.50 AED
  • 5 mg: 734.50 AED
  • 1 mg: 1,146 AED
  • 7 mg: 1,440 AED
  • 4 mg: 1,712 AED
 

These are the standard medication prices across pharmacies and providers in the UAE.

 

At Endocare, Wegovy is offered as part of a structured monthly programme starting from 1,990 AED per month, which reflects the combined medical and lifestyle support included in the plan rather than the medication alone. The package includes the Wegovy medication, unlimited specialist consultations, unlimited health coaching sessions, regular blood tests and body-composition analysis. Programmes are organised on a monthly basis, with ongoing review and adjustment based on your progress and treatment response.

 

Your total Wegovy treatment cost may include:

 

  • The medication itself, prescribed at the appropriate dose
  • Initial and follow-up consultation fees
  • Baseline and follow-up blood tests to keep treatment safe
  • Optional nutritional and behavioural coaching
 

Because plans differ from patient to patient, the easiest way to get a clear number is to speak with the clinic directly. For a detailed breakdown of pricing, including dose-specific costs and what is included in our package versus pay-as-you-go option, see our dedicated how much Wegovy costs in Dubai page.

Wegovy is a prescription-only medication. The safest way to access it in Dubai is through a licensed clinic where a doctor evaluates your eligibility before prescribing.

 

A few practical rules:

 

  • Wegovy should be prescribed by a qualified doctor after a medical assessment.
  • Avoid buying Wegovy from unverified online sellers. Counterfeit or improperly stored pens are a real safety risk.
  • Licensed clinics can confirm the medication is genuine, correctly dosed and safely administered.
 

At Endocare, Wegovy is prescribed as part of a structured programme rather than sold as a standalone product. If you are weighing up where to start, our guide on how to choose a weight loss clinic in Dubai walks through what actually matters.

Your first consultation is designed to give you clarity, not a hard sell. It usually takes about an hour, in person at our Dubai Healthcare City clinic or via secure telemedicine if that suits you better.

 

During your consultation, your doctor will typically:

 

  • Review your weight history and previous weight-loss attempts
  • Assess appetite patterns, eating behaviours and daily routine
  • Measure BMI and review key health markers
  • Discuss existing conditions and any medications you are taking
  • Determine whether Wegovy is the right option for you
  • Explain the dosing plan and how treatment progresses over time
  • Introduce you to our lifestyle coach and nutritionist, so you get a full picture of how the treatment works beyond the medication
 

You will also have time to ask questions about expected outcomes, side effects and what long-term management looks like. Wegovy can be started in the same week if appropriate, often with same-day medication delivery in Dubai.

 

If you are ready to start, you can book a GLP-1 weight-loss consultation directly.

Wegovy treatment is structured and predictable, which makes the journey easier to plan around your life.

 

  • Initial phase: in the first few weeks, most patients notice changes in appetite and portion tolerance as the body adapts. Some patients start to see weight changes from around week 2 onwards. If weight loss does not set in straight away, there is no need to worry, as it is individual how quickly each person’s body responds to the medication.
  • Dose adjustment phase: as the dose increases at planned intervals, appetite regulation becomes more consistent and eating patterns stabilise.
  • Ongoing treatment phase: with continued use and lifestyle support, many patients experience steady weight reduction over several months.
  • Maintenance phase: once you reach your target weight, you and your doctor usually begin to slowly reduce the dose or increase the intervals between injections, as advised. Lifestyle coaching continues throughout, so you stabilise your weight at a progressively lower dose while keeping the habits that got you there.
 

At every step, body-composition analysis helps make sure that what you are losing is fat rather than muscle. Preserving muscle matters for metabolic health and for keeping weight off after treatment is tapered. You can read more about this in our piece on GLP-1 and muscle loss.

Wegovy, Ozempic and Mounjaro are all prescription injections used in medically supervised weight-management or diabetes care, but they are not interchangeable.

 

A short orientation:

 

  • Wegovy (semaglutide 2.4 mg) is licensed for chronic weight management. It works on a single hormonal pathway, GLP-1.
  • Ozempic (semaglutide 0.25 to 2 mg) is licensed for type 2 diabetes. Same active ingredient as Wegovy, different label and dose range.
  • Mounjaro (tirzepatide) is licensed for type 2 diabetes and, increasingly, for chronic weight management depending on the market. It works on two pathways, GLP-1 and GIP.
 

Which one suits you is a clinical decision, not a preference. It depends on your medical profile, your goals, what you have tried before and how your body has responded. For a side-by-side breakdown, see our Ozempic vs Wegovy comparison and the broader Mounjaro vs Ozempic vs Wegovy guide.

Wegovy works at a hormonal level, but it does not work in a vacuum. Patients who see the most stable progress combine the medication with practical lifestyle support.

 

In our supervised programmes, the basics that tend to make the biggest difference are:

 

  • Protein-forward meals, which support satiety and help preserve lean muscle
  • Adequate hydration, especially during dose increases, to reduce nausea and digestive discomfort
  • Simple, balanced food choices, avoiding heavy or fried meals while appetite signals are adjusting
  • Regular movement, such as walking or light exercise, to support metabolic function
  • Consistent sleep, since disrupted sleep can interfere with hunger regulation
 

At Endocare, this support is built into the programme rather than left as a homework list. Patients have access to a clinical nutritionist and lifestyle coach, plus ongoing WhatsApp support between visits. You can read more in our piece on daily habits that help GLP-1 medications work better.

Wegovy affects appetite signalling, digestion and metabolic balance, which is why choosing the right clinical team matters more than choosing the medication itself.

 

Endocare Clinic is a Dubai Healthcare City licensed endocrinology and metabolic-health centre. Treatment is led by Dr Hecham Harb, Consultant Endocrinologist and Medical Director, with over 20 years of international experience in obesity and diabetes care. He is a Fellow of the Royal Australian College of Physicians (FRACP) in Endocrinology, and an honorary fellow in obesity and weight control at Austin Health, Melbourne. Wegovy is prescribed in line with Dubai Health Authority regulation.

 

What sets the programme apart:

 

  • Treatment overseen by qualified consultant endocrinologists with specialist expertise in obesity and metabolic care
  • Personalised dosing plans based on tolerance and response, not a one-size schedule
  • Body-composition analysis at every visit, so you track fat and muscle, not just total weight
  • Lifestyle coaching led by a clinical dietitian, integrated with medical care rather than billed as an upsell
  • Ongoing follow-up to monitor safety, progress and side effects
  • Same-day Wegovy delivery in Dubai with no markup on the pharmacy price
 

For Dubai residents, you can also browse our wider Dubai weight-loss clinic page for an overview of services beyond Wegovy.

Most patients notice changes in appetite within the first few weeks. Visible weight loss usually becomes more obvious after three to four weeks, and tends to be more pronounced as the dose increases and is maintained consistently. The individual response varies significantly. Some patients experience noticeable weight loss almost from the beginning, while others need a higher dose before they see results. Both patterns are completely normal.

Outcomes are individual, but the STEP 1 trial reported an average reduction of about 15 percent of body weight at 68 weeks. At Endocare, supervised programme patients typically lose 3 to 4 kg per month, with around 13 kg achievable in the first three months when lifestyle coaching is followed alongside medication.

Yes. Wegovy is a prescription-only medication in the UAE and must be prescribed by a licensed doctor after a medical evaluation.

They are different treatments with different mechanisms. Wegovy works on a single hormonal pathway, Mounjaro works on two, and Ozempic is the same active ingredient as Wegovy but licensed for diabetes. The right choice depends on your medical profile and is decided by a doctor, not by general preference.

Wegovy should only be obtained through licensed clinics or pharmacies. Unverified online sources may sell counterfeit or improperly stored medication, which is a real safety risk.

Wegovy is intended for long-term weight management. Treatment duration varies based on your response, tolerance and clinical goals, and is reviewed regularly with your doctor.

Appetite regulation may gradually return after treatment stops. Without ongoing lifestyle support, some patients regain weight over time, which is why Endocare focuses on sustainable habit change throughout treatment.

Wegovy can usually be continued during Ramadan with practical adjustments to dose timing, hydration and meal planning. Speak to your specialist before Ramadan to plan ahead. We cover this in detail in our guide to weight-loss injections during Ramadan.

Coverage varies by provider and policy. In many cases, weight-management medications are not covered, though they may be reimbursed when prescribed for diabetes or prediabetes. Consultations and lab tests are often covered. Endocare provides the documentation you need, but final approval sits with your insurer.

Wegovy is given as a once-weekly subcutaneous injection into the abdomen, thigh or upper arm. You receive clear instructions on technique, storage and safe disposal before starting treatment.

Wegovy works best when it is prescribed and managed by a specialist who can adjust treatment to how your body actually responds. If you are ready to take the next step, speak to the Endocare team.

Book a Wegovy consultation in Dubai

Prefer to chat first? WhatsApp the Endocare team and we will answer your questions and help you book.

Book Your Consultation

  • Specialist consultation
  • Personalized Coaching
  • Body Composition Analysis
Book your consultation

Not in Dubai?

Explore Wegovy injection in Abu Dhabi

Not in Dubai?

Explore Wegovy injection in Abu Dhabi